Clinical success

The DigniCap Clinical trial demonstrated a success rate of about 66% for patients on Taxane-based regimens. (Success is defined as losing less than 50% of their hair.) Since that published study, many of our patients have reported an even higher degree of success. 

There are many factors that go into a success story, and some patients have also found that their hair grows back faster and at a more normal texture when using scalp cooling – even if they experienced substantial hair loss. In fact, some scalp cooling patients have reported new hair growing back while still going through chemotherapy.



An Italian study published in 2019 assessed the effectiveness of scalp cooling with DigniCap for patients receiving adjuvant chemotherapy with an anthracycline with or without taxanes. DigniCap was able to prevent significant hair loss in 43% of breast cancer patients receiving adjuvant chemotherapy.

For more information about the DigniCap and anthracyclines CLICK HERE.